994OLenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC)
Makker, V, Taylor, M H, Aghajanian, C, Oaknin, A, Mier, J, Cohn, A L, Marin, M Romeo, Lorenzo, R Bratos, Brose, M S, DiSimone, C, Messing, M J, Stepan, D E, Dutcus, C E, Wu, J, Schmidt, E V, Orlowski,Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz250.002
Date:
October, 2019
File:
PDF, 91 KB
2019